免疫疗法治疗脑胶质瘤。
Immunotherapy for the treatment of glioblastoma.
机构信息
Department of Neurology, Dartmouth Medical School and Dartmouth-Hitchcock Medical Center, Lebanon, NH.
出版信息
Cancer J. 2012 Jan-Feb;18(1):59-68. doi: 10.1097/PPO.0b013e3182431a73.
Abstract
Glioblastoma, the most aggressive primary brain tumor, thrives in a microenvironment of relative immunosuppression within the relatively immune-privileged central nervous system. Despite treatments with surgery, radiation therapy, and chemotherapy, prognosis remains poor. The recent success of immunotherapy in the treatment of other cancers has renewed interest in vaccine therapy for the treatment of gliomas. In this article, we outline various immunotherapeutic strategies, review recent clinical trials data, and discuss the future of vaccine therapy for glioblastoma.
摘要
胶质母细胞瘤是最具侵袭性的原发性脑肿瘤，在中枢神经系统相对免疫豁免的微环境中蓬勃生长。尽管采用了手术、放疗和化疗等治疗方法，但预后仍然较差。免疫疗法在治疗其他癌症方面的近期成功重新激发了人们对胶质母细胞瘤疫苗治疗的兴趣。本文概述了各种免疫治疗策略，回顾了最近的临床试验数据，并讨论了胶质母细胞瘤疫苗治疗的未来。
相似文献
1
Immunotherapy for the treatment of glioblastoma.免疫疗法治疗脑胶质瘤。
Cancer J. 2012 Jan-Feb;18(1):59-68. doi: 10.1097/PPO.0b013e3182431a73.
2
Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies.当前胶质母细胞瘤靶向治疗的挑战：聚焦免疫治疗策略。
Int J Mol Sci. 2021 Mar 28;22(7):3493. doi: 10.3390/ijms22073493.
3
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment.多形性胶质母细胞瘤中的免疫逃逸与免疫疗法治疗的适应性改变。
Front Immunol. 2020 Oct 15;11:582106. doi: 10.3389/fimmu.2020.582106. eCollection 2020.
4
Vaccine-Based Immunotherapeutics for the Treatment of Glioblastoma: Advances, Challenges, and Future Perspectives.用于治疗胶质母细胞瘤的基于疫苗的免疫疗法：进展、挑战与未来展望
World Neurosurg. 2018 Dec;120:302-315. doi: 10.1016/j.wneu.2018.08.202. Epub 2018 Sep 6.
5
Immunotherapy for glioblastoma: the promise of combination strategies.胶质母细胞瘤的免疫治疗：联合策略的前景。
J Exp Clin Cancer Res. 2022 Jan 25;41(1):35. doi: 10.1186/s13046-022-02251-2.
6
Vaccine-based immunotherapy for glioblastoma.基于疫苗的胶质母细胞瘤免疫疗法。
CNS Oncol. 2013 Jul;2(4):331-49. doi: 10.2217/cns.13.29.
7
Current Immunotherapies for Glioblastoma Multiforme.目前用于多形性胶质母细胞瘤的免疫疗法。
Front Immunol. 2021 Mar 9;11:603911. doi: 10.3389/fimmu.2020.603911. eCollection 2020.
8
Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development.胶质母细胞瘤的免疫治疗：肿瘤模型开发中的当前策略和挑战。
Cells. 2021 Jan 29;10(2):265. doi: 10.3390/cells10020265.
9
The network of immunosuppressive pathways in glioblastoma.胶质母细胞瘤中的免疫抑制通路网络。
Biochem Pharmacol. 2017 Apr 15;130:1-9. doi: 10.1016/j.bcp.2016.12.011. Epub 2016 Dec 22.
10
Immunotherapy for glioblastoma: current state, challenges, and future perspectives.胶质母细胞瘤的免疫治疗：现状、挑战与未来展望。
Cell Mol Immunol. 2024 Dec;21(12):1354-1375. doi: 10.1038/s41423-024-01226-x. Epub 2024 Oct 15.
引用本文的文献
1
Harnessing Immune Rejuvenation: Advances in Overcoming T Cell Senescence and Exhaustion in Cancer Immunotherapy.利用免疫恢复：癌症免疫治疗中克服T细胞衰老和耗竭的进展
Aging Cell. 2025 May;24(5):e70055. doi: 10.1111/acel.70055. Epub 2025 Apr 3.
2
Complex Diagnostic Challenges in Glioblastoma: The Role of F-FDOPA PET Imaging.胶质母细胞瘤的复杂诊断挑战：F-FDOPA PET成像的作用
Pharmaceuticals (Basel). 2024 Sep 15;17(9):1215. doi: 10.3390/ph17091215.
3
Integrating neurosurgery with immunotherapy: novel approaches to brain cancer treatment.将神经外科与免疫疗法相结合：脑癌治疗的新方法。
Neurosurg Rev. 2024 Sep 17;47(1):623. doi: 10.1007/s10143-024-02849-4.
4
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM).多形性胶质母细胞瘤（GBM）的耐药机制及当前治疗选择
Cancers (Basel). 2023 Apr 1;15(7):2116. doi: 10.3390/cancers15072116.
5
To Explore the Stem Cells Homing to GBM: The Rise to the Occasion.探索归巢至胶质母细胞瘤的干细胞：应时而起。
Biomedicines. 2022 Apr 24;10(5):986. doi: 10.3390/biomedicines10050986.
6
The phosphatase and tensin homolog gene inserted between NP and P gene of recombinant New castle disease virus oncolytic effect test to glioblastoma cell and xenograft mouse model.磷酸酶和张力蛋白同源基因插入重组新城疫病毒 NP 和 P 基因之间对神经胶质瘤细胞和异种移植鼠模型的溶瘤作用研究。
Virol J. 2022 Jan 29;19(1):21. doi: 10.1186/s12985-022-01746-w.
7
Expression, prognostic significance and therapeutic implications of PD-L1 in gliomas.PD-L1 在脑胶质瘤中的表达、预后意义及治疗意义。
Neuropathol Appl Neurobiol. 2022 Feb;48(1):e12767. doi: 10.1111/nan.12767. Epub 2021 Oct 20.
8
In vitro radiotherapy and chemotherapy alter migration of brain cancer cells before cell death.体外放疗和化疗在癌细胞死亡前改变其迁移能力。
Biochem Biophys Rep. 2021 Jul 13;27:101071. doi: 10.1016/j.bbrep.2021.101071. eCollection 2021 Sep.
9
Microphysiological systems to study tumor-stroma interactions in brain cancer.用于研究脑癌中肿瘤-基质相互作用的微生理系统。
Brain Res Bull. 2021 Sep;174:220-229. doi: 10.1016/j.brainresbull.2021.06.012. Epub 2021 Jun 21.
10
The Survival Benefit of Postoperative Bacterial Infections in Patients With Glioblastoma Multiforme: Myth or Reality?多形性胶质母细胞瘤患者术后细菌感染的生存获益：神话还是现实？
Front Neurol. 2021 Feb 5;12:615593. doi: 10.3389/fneur.2021.615593. eCollection 2021.
本文引用的文献
1
Postoperative infection may influence survival in patients with glioblastoma: simply a myth?术后感染是否会影响胶质母细胞瘤患者的生存：仅仅是一个传说？
Neurosurgery. 2011 Oct;69(4):864-8; discussion 868-9. doi: 10.1227/NEU.0b013e318222adfa.
2
Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma.易普利姆玛：一种抗 CTLA-4 抗体，用于转移性黑色素瘤。
Clin Cancer Res. 2011 Nov 15;17(22):6958-62. doi: 10.1158/1078-0432.CCR-11-1595. Epub 2011 Sep 7.
3
Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.高级别脑胶质瘤患者在接受放疗和替莫唑胺化疗后的免疫抑制。
Clin Cancer Res. 2011 Aug 15;17(16):5473-80. doi: 10.1158/1078-0432.CCR-11-0774. Epub 2011 Jul 7.
4
A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma.一项Ⅰ/Ⅱ期临床试验，旨在研究术后自体树突状细胞瘤苗在恶性脑胶质瘤患者中的不良反应和治疗效果。
J Clin Neurosci. 2011 Aug;18(8):1048-54. doi: 10.1016/j.jocn.2010.11.034. Epub 2011 Jun 28.
5
Heat shock protein-peptide complex in the treatment of glioblastoma.热休克蛋白-肽复合物在治疗脑胶质母细胞瘤中的应用。
Expert Rev Vaccines. 2011 Jun;10(6):721-31. doi: 10.1586/erv.11.49.
6
Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging.通过髓过氧化物酶磁共振成像区分炎症、肿瘤和肿瘤周围水肿。
Clin Cancer Res. 2011 Jul 1;17(13):4484-93. doi: 10.1158/1078-0432.CCR-11-0575. Epub 2011 May 10.
7
Do we need novel radiologic response criteria for brain tumor immunotherapy?我们是否需要针对脑肿瘤免疫治疗的新的放射学反应标准？
Expert Rev Neurother. 2011 May;11(5):619-22. doi: 10.1586/ern.11.49.
8
Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.新诊断的多形性胶质母细胞瘤患者在放化疗后接受淋巴结内自体肿瘤裂解物-树突状细胞疫苗接种的免疫反应。
J Immunother. 2011 May;34(4):382-9. doi: 10.1097/CJI.0b013e318215e300.
9
Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β.效应 T 细胞浸润对胶质母细胞瘤患者的生存有积极影响，但会被肿瘤衍生的 TGF-β所抑制。
Clin Cancer Res. 2011 Jul 1;17(13):4296-308. doi: 10.1158/1078-0432.CCR-10-2557. Epub 2011 Apr 8.
10
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.CD40 激动剂可改变肿瘤基质，并在小鼠和人类中显示出对胰腺癌的疗效。
Science. 2011 Mar 25;331(6024):1612-6. doi: 10.1126/science.1198443.
Zotero 插件